Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04455698 · ClinicalTrials.gov registry record · NA
Engaging and Activating Cancer Survivors in Genetic Services Study
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 391
- Enrollment target
NCT04455698: Completed NA study, sponsored by University of Chicago.
NCT04455698 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 391 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04455698, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 391 participants
- Enrollment target
Study Summary
To address the gap in access to genetic services, this study will evaluate the effectiveness of an adapted model of remote delivery of genetic services to increase the uptake of recommended genetic assessment and testing in childhood cancer survivors.
Primary Outcome
Primary composite outcome collected via remote services records-Yes/No
Interventions
- BEHAVIORAL Usual Care Arm
- BEHAVIORAL Remote Telegenetic Counseling by Phone
- BEHAVIORAL Remote Telegenetic Counseling by Videoconferencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 391 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT04455698 record still lists
NCT04455698 is an interventional study that assigns participants to a tested intervention. The registered 391 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care Arm is the first listed.
NCT04455698 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04455698 about?
NCT04455698 is a clinical study titled "Engaging and Activating Cancer Survivors in Genetic Services Study". To address the gap in access to genetic services, this study will evaluate the effectiveness of an adapted model of remote delivery of genetic services to increase the uptake of recommended genetic assessment and testing in childhood cancer survivors.
What is the current status of trial NCT04455698?
This trial is currently completed. It is a NA study. The enrollment target is 391 participants. The study started on 2021-08-16. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT04455698?
The interventions under investigation include: Usual Care Arm (BEHAVIORAL), Remote Telegenetic Counseling by Phone (BEHAVIORAL), Remote Telegenetic Counseling by Videoconferencing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04455698?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04455698's enrollment target sits among peer trials
391 269th of 2000 higher than 1,732 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI